Effectiveness of chelation therapy with time after acute vanadium intoxication

Area of Science:

• Toxicology
• Environmental Health
• Pharmacology

Background:

• Vanadium compounds, such as sodium metavanadate, pose toxicological risks.
• Chelation therapy is a potential treatment for heavy metal poisoning.
• The timing of chelation therapy can influence its effectiveness.

Purpose of the Study:

• To investigate the impact of delayed chelation therapy on vanadium excretion and tissue concentration.
• To evaluate the efficacy of ascorbic acid, deferoxamine mesylate (DFOA), and Tiron in treating vanadium toxicity.
• To determine the optimal time window for administering chelating agents after vanadium exposure.

Main Methods:

• Male Swiss mice were administered sodium metavanadate intraperitoneally.
• Chelating agents (ascorbic acid, DFOA, Tiron) were administered at varying intervals (0, 0.5, 2, 8 hours) post-vanadium exposure.
• Vanadium excretion in urine and feces was measured daily for four days.
• Kidney vanadium concentrations were assessed four days after vanadium administration.

Main Results:

• Vanadium excretion was most rapid within the first 24 hours after exposure.
• Tiron significantly increased urinary vanadium excretion, while DFOA enhanced fecal excretion on Day 1.
• Both DFOA and Tiron treatments significantly reduced kidney vanadium levels.
• Increasing the time interval between vanadium administration and chelation therapy markedly reduced the effectiveness of both agents in promoting vanadium elimination and lowering tissue concentrations.

Conclusions:

• The efficacy of chelation therapy for vanadium toxicity is highly dependent on the timing of administration relative to exposure.
• Early intervention with chelating agents like DFOA and Tiron is crucial for maximizing vanadium removal and minimizing tissue accumulation.
• Further research may explore novel strategies to enhance chelation therapy effectiveness when delayed.